STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia

Fumihiro Ishida1, Kazuyuki Matsuda, Nodoka Sekiguchi

  • 1Division of Hematology, Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan; Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan.

Cancer Science
|December 20, 2013
PubMed

Insights

Mutations in the STAT3 gene

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Large granular lymphocyte leukemia (LGL L) encompasses T-cell LGL L (T-LGL L) and chronic lymphoproliferative disorders of NK cells (CLPD-NK).
  • STAT3 gene mutations are implicated in various hematologic malignancies.

Purpose of the Study:

  • To investigate STAT3 gene mutations in Asian cohorts of T-LGL L and CLPD-NK.
  • To determine the correlation between STAT3 mutations and clinical features, such as pure red cell aplasia (PRCA).

Main Methods:

  • Direct sequencing and allele-specific (AS) PCR were used to identify mutations in the SH2 domain of the STAT3 gene.
  • AS-quantitative PCR was employed to monitor mutation levels over time.

Main Results:

  • STAT3 mutations (Y640F and D661Y) were identified in 47.6% of T-LGL L and 27.2% of CLPD-NK patients.
  • STAT3 mutations were significantly associated with pure red cell aplasia (PRCA) (P = 0.005).
  • Mutations remained stable for over 5 years in some patients.

Conclusions:

  • The SH2 domain of the STAT3 gene is frequently mutated in Asian patients with T-LGL L and CLPD-NK.
  • STAT3 mutations are closely correlated with the development of PRCA in these leukemia subtypes.